|Bid||3,042.00 x 0|
|Ask||3,042.50 x 0|
|Day's Range||3,015.00 - 3,053.00|
|52 Week Range||2,336.50 - 4,240.00|
|Beta (3Y Monthly)||1.50|
|PE Ratio (TTM)||11.30|
|Earnings Date||Feb 20, 2019 - Feb 25, 2019|
|Forward Dividend & Yield||2.03 (6.70%)|
|1y Target Est||3,825.26|
British American Tobacco's (BAT) proposed takeover of e-cigarette maker Twisp won approval from South Africa's Competition Tribunal on Tuesday after the UK-based group agreed to a series of conditions. The local unit of BAT, the world's second-largest tobacco company by sales, announced the deal in 2017 as part of its efforts to increase its offering of so-called next-generation products or alternatives to smoking cigarettes. BAT, like rivals, is striving for a bigger chunk of the global market for smoking alternatives as volumes of traditional cigarettes continue to slide.
London's FTSE 100 ended flat on Thursday despite a profit miss from Shell and dampened hopes of big U.S. interest rate cuts, while the mid-cap FTSE 250 index slipped after Brexit worries led the Bank of England to cut its growth forecasts. Losses were contained by BAT and as London Stock Exchange surged 6.5% to an all-time high after a deal to buy financial information firm Refinitiv, in which Reuters News parent Thomson Reuters holds a 45% stake.
Based on British American Tobacco p.l.c.'s (LON:BATS) earnings update in December 2018, analyst consensus outlook...
In March 2019, British American Tobacco p.l.c. (LON:BATS) released its most recent earnings announcement, which...
The warning highlighted the challenges dogging the tobacco industry as smokers, particularly in the United States, turn to less harmful alternatives such as e-cigarettes and vaping products. The maker of Lucky Strike and Dunhill cigarettes said it expects global industry volumes to fall around 3.5% this year, compared with its earlier estimate of a 3% drop. BAT said it would invest further in what it calls its "New Category" business and announced plans to consolidate the portfolio, which makes tobacco heating product glo and Vype e-cigarettes as well as snuff and nicotine pouches.
London's FTSE 100 fell almost 1% on Friday after U.S. President Donald Trump's threat of tariffs on Mexico and disappointing manufacturing data from China stoked global downturn fears. The main index hit a more than two-and-a-half month low, while the mid-cap FTSE 250 fell 0.7%, with both recording their first monthly falls this year. Data on Friday showed China's factory activity shrank more than expected in May, another of the economic ramifications of the Sino-U.S. trade dispute.
London's top share index rose on Thursday as the pound slipped on concerns that outgoing Prime Minister Theresa May's successor might push for a hard Brexit, helping more internationally focused stocks gain. The FTSE 100, whose components earn a large chunk of their revenue from outside the UK, rose 0.5%.
British tobacco company Imperial Brands Plc said on Wednesday U.S. industry volumes fell 6.4% in the four weeks to May 18, smaller than the 11.2 percent decline that research firm Nielsen's data showed on Monday. The Nielsen report had pushed down shares of Imperial Brands, British American Tobacco and Altria between 1% and 3% on Tuesday. Imperial Brands said late on Wednesday that its figures were based on data from MSAi, which compiles data from over 300,000 stores, representing at least 95% of U.S. tobacco volumes.
London's FTSE 100 weakened on Wednesday as an escalation in the China-U.S. trade conflict coupled with tensions over budgetary rules between Italy and the European Union hurt investors' appetite for risk across the board. Both the main index and the more domestically-focussed midcap index were down 0.7% by 0710 GMT. China's Communist Party newspaper warned on Wednesday that Beijing was ready to use its influence over the supply of rare earths to strike back against the United States in an increasingly bitter trade dispute.
Altria and British American Tobacco shares fell Tuesday. Cigarettes volumes fell 11.2% in the four-week period ended May 18, according to Nielsen data published Tuesday. Tobacco stocks slid Tuesday after new Nielsen data showed cigarette sales declined sharply in the past month.
Brazil is suing Philip Morris International and British American Tobacco over the financial toll of smoking. The Brazilian attorney general's office is seeking reimbursement for costs over the past five years, as well as future costs, of treating patients with 26 tobacco-related diseases. Public health groups praised Brazil's lawsuit.
The FTSE 100 was 0.1% lower, while the mid-cap FTSE 250 rose 0.4%. British American Tobacco and Imperial Brands were among the biggest drags on the main index after data from Nielsen showed cigarette industry volumes deteriorated in the four weeks to May 18.
European shares sank on Thursday as the latest round of U.S.-China trade friction and a soft set of business surveys sapped investors' risk appetite, while British Prime Minister Theresa May faced growing pressure to quit. By 0811 GMT, the pan-European STOXX 600 had dropped 0.8%, with Germany's traditionally trade-sensitive DAX down 1.11%. The latest evidence of the impact the conflict is having on Europe's largest economy came in the flash purchasing managers surveys, which showed activity in Germany's services and manufacturing sectors fell in May.
European shares fell sharply on Thursday, as investors grappled with the latest round of U.S.-China trade friction while British Prime Minister Theresa May faced growing pressure to resign. European auto and mining sector indexes shed 2.80% and 1.04% respectively.
People using e-cigarettes to quit smoking are about 95% more likely to report success than those trying to quit without help from any stop-smoking aids, according to the results of a large study in England. The research, funded by the charity Cancer Research UK and published in the journal Addiction on Thursday, analyzed success rates of several common stop-smoking methods - including e-cigarettes, nicotine replacement therapy (NRT) patches and gum, and Pfizer's varenicline, sold as Champix in the UK. It also adjusted for a wide range of factors that might influence success rates for quitting - such as age, social level, degree of cigarette addiction, previous attempts to quit, and whether quitting was gradual or abrupt.
Brazil is suing the world's largest cigarette makers, British American Tobacco Plc and Philip Morris International, in a landmark case aimed at recovering the public health treatment costs of tobacco-related diseases over the last five years. The Brazilian solicitor general's office, known as the AGU, announced the lawsuit late on Tuesday against the two multinational companies and their Brazilian subsidiaries, who produce most of the cigarettes sold in the country. The suit seeks to recover the cost of treating patients for 26 illnesses related to smoking tobacco or coming into contact with cigarette smoke, the AGU said in a statement.
The exporter-heavy FTSE 100 index gained on the back of a weaker pound on Wednesday as lawmakers signaled they would not back Prime Minister Theresa May's latest Brexit compromise, while Marks & Spencer slumped after a discounted rights issue. The main index, whose companies get more than two-thirds of their profit from abroad, advanced 0.6% by 0727 GMT while the more domestically-focussed FTSE 250 was up 0.1%. Internationally-exposed companies British American Tobacco , Unilever and Diageo were among the biggest support to the blue-chip index.
A dozen states and more than 450 local governments have increased the tobacco buying age to 21. Altria, Juul and British American Tobacco are supporting the efforts. A movement to raise the smoking age across the U.S. to 21 has an unlikely supporter: Big Tobacco.
Battered by headwinds from changing consumer habits and a heavy-handed FDA, BTI is down. If the fundamentals check out, this could be a value buy for investors.